We have come across the recent endeavors of your group on the DYRK1A inhibitors for human diabetes, and read some of your publication where in your team is developing Harmine based derivatives for the DYRK1A inhibition and human β-cell proliferation capability. In this context as we are one of the key suppliers of Natural product Harmine and Harmaline would like to inform you that we have a good stock of Harmine and Harmaline in house and can offer you at a very attractive price.
Description: We have come across the recent endeavors of your group on the DYRK1A inhibitors for human diabetes, and read some of your publication where in your team is developing Harmine based derivatives for the DYRK1A inhibition and human β-cell proliferation...